```html

Azithromycin Allergy – Comprehensive Medical Guide

Overview

Azithromycin is a macrolide antibiotic frequently prescribed for respiratory infections, skin infections, sexually transmitted diseases, and a number of other bacterial illnesses. An azithromycin allergy is an immune‑mediated reaction that occurs when the body mistakenly identifies the drug (or a component of its formulation) as harmful.

• Who it affects: Anyone can develop an allergy to azithromycin, but it is more commonly reported in adults than in children.
• Prevalence: True IgE‑mediated azithromycin allergy is rare, estimated at < 0.1 %–0.5 % of all patients exposed to the drug.<sup>1</sup> However, non‑allergic hypersensitivity reactions (e.g., rash, gastrointestinal upset) are more common, occurring in up to 10 % of users.<sup>2</sup>

Because azithromycin is widely used (over 30 million prescriptions in the United States annually)<sup>3</sup>, even a low prevalence translates to thousands of individuals who may experience an allergic reaction each year.

Symptoms

Allergic reactions can range from mild skin involvement to life‑threatening anaphylaxis. Below is a complete list of reported manifestations, grouped by severity.

Mild to Moderate Reactions

• Urticaria (hives): Raised, red, itchy welts that may appear anywhere on the body.
• Pruritus: Generalized itching without visible rash.
• Erythematous rash: Flat, red patches that can coalesce.
• Angio‑edema: Swelling of the lips, tongue, face, or eyelids; often painless but can cause discomfort.
• Gastro‑intestinal symptoms: Nausea, vomiting, abdominal cramping—these are usually non‑allergic but can accompany an allergic response.

Severe (Systemic) Reactions

• Anaphylaxis: Rapid onset of throat tightness, difficulty breathing, wheezing, hypotension, dizziness, or loss of consciousness. This is a medical emergency.
• Serum sickness‑like reaction: Fever, joint pain, lymphadenopathy, and a rash that appears 1–2 weeks after exposure.
• Stevens‑Johnson syndrome (SJS) / Toxic epidermal necrolysis (TEN): Severe skin detachment, mucosal involvement, and painful blistering; requires immediate hospitalization.
• Bronchospasm: Wheezing and shortness of breath, often in patients with underlying asthma.

Causes and Risk Factors

Azithromycin allergy is an immune reaction that can be either IgE‑mediated (classic allergy) or delayed‑type hypersensitivity. The exact antigenic determinant is not fully understood, but several factors increase the likelihood of developing a reaction.

Primary Causes

• Drug protein conjugates: Azithromycin can bind to body proteins, forming a new antigen that triggers an immune response.
• Excipient sensitivity: Some formulations contain inactive ingredients (e.g., lactose, dyes) that may be the real allergen.
• Cross‑reactivity: Rarely, patients allergic to other macrolides (erythromycin, clarithromycin) may react to azithromycin.

Risk Factors

• Previous allergic reaction to any macrolide or to azithromycin itself.
• History of atopy (eczema, allergic rhinitis, asthma).
• Multiple drug exposures within a short period (e.g., during a hospital stay).
• Genetic predisposition: certain HLA alleles have been linked to drug hypersensitivity, though specific markers for azithromycin are still under investigation.
• Underlying immune disorders or immunosuppression (paradoxically can increase risk of delayed reactions).

Diagnosis

Diagnosing an azithromycin allergy involves a combination of clinical history, physical examination, and, when necessary, targeted testing.

Step‑by‑Step Approach

1. Detailed history: Timing of symptom onset relative to the first dose, nature of symptoms, previous drug exposures, and any co‑administered medications.
2. Physical exam: Look for skin changes, respiratory distress, or signs of systemic involvement.
3. Skin testing (rarely performed): Prick or intradermal testing with diluted azithromycin solution can be done in specialized allergy centers. Sensitivity and specificity are not well‑established, so a negative test does not completely rule out allergy.
4. Drug provocation test (DPT): Considered the gold standard; a supervised, graded dose of azithromycin is administered under close monitoring. This is only performed when the benefit outweighs risk and after negative skin testing.
5. Laboratory tests: Serum tryptase (if anaphylaxis is suspected) and specific IgE (currently not commercially available for azithromycin). CBC and liver function may be checked to rule out other causes.

Because testing is complex and not widely available, many clinicians rely on a "clinical diagnosis" based on history and symptom pattern.

Treatment Options

Management depends on the severity of the reaction.

Mild to Moderate Reactions

• Antihistamines: Oral cetirizine 10 mg daily or diphenhydramine 25–50 mg every 6 hours.
• Topical corticosteroids: Hydrocortisone 1 % cream for localized rash.
• Systemic corticosteroids: Prednisone 20–40 mg daily for 5–7 days if rash is extensive or angio‑edema is present.
• Discontinuation of azithromycin: Switch to an alternative antibiotic (e.g., doxycycline, levofloxacin) after susceptibility testing.

Severe Reactions (Anaphylaxis, SJS/TEN)

• Epinephrine: 0.3 mg intramuscularly (1 mg/mL concentration) into the anterolateral thigh; repeat every 5–15 minutes if symptoms persist.
• Adjunctive therapy: Intravenous antihistamines (diphenhydramine 50 mg), bronchodilators (albuterol), and aggressive fluid resuscitation for hypotension.
• Hospital admission: Monitoring for biphasic reactions, airway support, and specialist care for SJS/TEN (burn unit or dermatology).
• Corticosteroids: IV methylprednisolone 1–2 mg/kg may be given, though evidence for impact on anaphylaxis outcomes is mixed.

Long‑Term Management

• Prescription of an epinephrine auto‑injector (EpiPen®) for patients who have experienced anaphylaxis.
• Referral to an allergist for formal testing and documentation of the allergy.
• Education on cross‑reactive drugs and provision of an allergy card or bracelet.

Living with Azithromycin Allergy

With proper precautions, individuals can avoid accidental exposure and maintain a normal lifestyle.

Practical Tips

• Medical alert identification: Wear a bracelet or carry a card that clearly states “Allergic to azithromycin (macrolide) – avoid.”
• Inform all healthcare providers: Include the allergy in electronic medical records and verbal hand‑offs during each visit.
• Read medication labels: Over‑the‑counter (OTC) cough syrups, eye drops, and some veterinary products may contain azithromycin.
• Alternative antibiotics: Discuss with your doctor a list of safe substitutes based on the infection being treated.
• Carry emergency medication: If prescribed an epinephrine auto‑injector, ensure it is never out of date and is accessible at all times.
• Follow‑up: Schedule an allergy clinic visit within 4–6 weeks after a reaction to confirm diagnosis and receive a written exemption.

Prevention

Preventing an allergic reaction is essentially preventing exposure.

• Allergy documentation: Ensure the allergy is recorded in all pharmacy and hospital systems.
• Ask before every prescription: Even if you have taken azithromycin years ago, confirm you are not allergic before any new prescription.
• Educate family and caregivers: Children and elderly patients often rely on others for medication administration.
• Vaccination considerations: Some vaccine adjuvants contain macrolide preservatives; discuss with your provider if you have a known macrolide allergy.

Complications

If an azithromycin allergy is missed or untreated, several serious outcomes can occur:

• Progression to anaphylaxis: Delay in epinephrine administration increases mortality risk (estimated case‑fatality 0.5‑1 %).<sup>4</sup>
• Stevens‑Johnson syndrome / TEN: Up to 30 % mortality in TEN; long‑term sequelae include scarring, ocular damage, and chronic pain.
• Hospital readmission: Re‑exposure during a later illness can result in rapid decompensation.
• Psychological impact: Fear of medication can lead to medication non‑adherence and poorer infection control.

When to Seek Emergency Care

References

1. American Academy of Allergy, Asthma & Immunology. “Drug Allergy Overview.” 2023. https://www.aaaai.org
2. Mayo Clinic. “Azithromycin (Oral Route).” 2022. https://www.mayoclinic.org
3. CDC. “Antibiotic Use in the United States, 2022.” 2023. https://www.cdc.gov
4. World Health Organization. “Anaphylaxis: Clinical Guidelines.” 2021. https://www.who.int
5. Cleveland Clinic. “Stevens-Johnson Syndrome & Toxic Epidermal Necrolysis.” 2023. https://my.clevelandclinic.org

```